Clinical Trials Directory

Trials / Unknown

UnknownNCT05406141

Nutrition Sufficiency, Allergy Efficacy and Safety of Neocate Jr in Children With Food Protein Allergy

Nutrition Sufficiency, Allergy Efficacy and Safety of an Amino Acid-Based Formula Neocate Jr in Children With Food Protein Allergy

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Peking University Third Hospital · Academic / Other
Sex
All
Age
1 Year – 10 Years
Healthy volunteers
Not accepted

Summary

The main purpose of this study is to evaluate efficacy and safety of an amino acid-based formula Neocate Jr in children with food protein allergy, and to evaluate nutrition sufficiency of Neocate Jr in 1 to 10 years old children with food protein allergy.

Detailed description

This is an open, self-controlled multi-center clinical study. Target population is 1~10 years old children allergic to cow's milk and/or food protein, confirmed by pediatrician. The study plans to recruit about 50 subjects to have an intervention period of 4 weeks. Data will be collected at baseline, week 1, 2 and 4. The hypothesis is that the amino acid formula (Neocate Jr) is effective in relieving food protein allergy symptoms, and meanwhile supporting normal growth in children with food protein allergy. Efficacy parameters are the the improvement of food protein allergy symptoms (SCORAD score, serum IgE), growth and development index (weight, height, weight for height), and nutrition related labs (such as hemoglobin, total blood protein, albumin, pre-albumin).

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTAmino acid formula (Neocate Jr)Use Neocate Jr for 4 weeks, either as sole source of nutrition or oral nutritional supplement: * Sole source of nutrition: as far as possible \>7 days, especially newly diagnosed allergy children * Oral nutritional supplement (Neocate Jr ≥50% of daily total energy and the rest provided by food)

Timeline

Start date
2022-03-30
Primary completion
2022-12-30
Completion
2023-03-30
First posted
2022-06-06
Last updated
2022-06-06

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05406141. Inclusion in this directory is not an endorsement.